Antimicrobial Technologies for Enhanced Consumer Health

  • ID: 4451530
  • Report
  • Region: Global
  • 57 Pages
  • Frost & Sullivan
1 of 4
Novel Microbicidal Platforms Likely to Transform the Future of Global Consumer Health

FEATURED COMPANIES

  • Allvivo Vascular Inc., US
  • Chamgonano, China
  • MORE

Healthcare-associated infection (HAI) continues to be a significant global concern, hence there is growing research for developing new antimicrobial platforms that can significantly decrease the risk of microbial infections.

While metallic ions continue to be one of the most potent antimicrobial technology platform, several new innovations across antimicrobial polymers, peptides and naturally sourced agents will lead the global consumer health landscape.

Key opportunities for antimicrobial technologies will depend on the use of optimal combination of multiple microbicidal platforms for several consumer health applications.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allvivo Vascular Inc., US
  • Chamgonano, China
  • MORE

1. Executive Summary
1.1 Research Scope - Antimicrobial Technologies Transforming Consumer Health
1.2 Research Methodology
1.3 Key Findings - Antimicrobial Technologies Ideally Poised to Transform Consumer Health

2. Technology Overview
2.1 Rising Needs and Emerging Trends Across Antimicrobial Technologies
2.2 Key Capabilities Defining Antimicrobial Technologies
2.3 Diverse Antimicrobial Platforms Address Global Consumer Health Concerns
2.4 Metallic Ions Function by Inducing Cell Membrane Disruption
2.6 Antimicrobial Polymers Cause Cell Membrane Disruption
2.7 Polymeric Antimicrobials Have Growing Applications Across Medical Devices
2.8 Amphipathic Nature of Antimicrobial Peptides Enable Microbial Interaction
2.9 Antimicrobial Peptide Coatings Lead Dental Implants and Food Packaging Applications
2.10 Antimicrobial Quaternary Ammonium Compounds for Biocidal Applications
2.11 Quaternary Ammonium Compounds Frequently Used for Varied Sanitizing Applications
2.12 Biguanides and Amidines Enable Enhanced Antimicrobial Functions
2.13 Most Antiseptic Formulations Comprise Biguanides and Amidines
2.14 Phenolic Compounds and Aromatic Alcohols Induce Cytological Damage in Microorganisms
2.15 Consumer Disinfectants Leverage Antimicrobial Functions of Phenol and Derivatives
2.16 Growing Need for Environmental-friendly Products Fueling Growth of Natural Antimicrobials
2.17 Rising Preference of Natural Antimicrobials as Food Preservatives
2.18 Combination of Multiple Antimicrobial Ingredients Likely to Drive Future Innovations
2.19 Metallic Polymers Emerge as Potent Antimicrobial Agents

3. Key Research, Regional, and IP Trends
3.1 Rising Global Research on Antimicrobial Technologies Likely to Fuel New Innovations in the US
3.2 Europe to Witness Increasing Innovations in Antimicrobial Platforms
3.3 Asia Pacific Likely to Emerge as a Key Hub for New Antimicrobial Technologies
3.4 Mining the Global Patent Landscape for Novel Antimicrobial Technologies
3.5 North America Leads the Global IP Landscape for Antimicrobial Technologies
3.6 Summary of Key IP Trends
3.7 Analysis of Antimicrobial Applications of Leading Patent Holders

4. Overview of Stakeholder Initiatives
4.1 Medical Devices and Implants Constitute Some of the Key Stakeholder Initiatives
4.2 Disinfectants and Antimicrobial Coatings Dominate the Consumer Health Landscape
4.3 Antimicrobial Formulations for Enabling Hospital, Salon, and Pool Hygiene
4.4 PHMB-based Antimicrobials Lead Wound Dressing and Adhesive Applications

5. Future Perspectives
5.1 Sustained Interest in Antimicrobial Technology Research
5.2 Examples of Recent Research Across Antimicrobial Technologies
5.3 Technologies Redefining the Future of Global Antimicrobial Platforms

6. Growth Opportunities and Companies to Action
6.1 Growth Opportunities - Combining Antimicrobial Platforms
6.2 Growth Opportunities - Antimicrobial Peptides
6.3 Growth Opportunities - Natural Antimicrobials
6.4 Strategic Imperatives for Success and Growth
6.5 Companies to Action - Allvivo Vascular Inc., US
6.6 Companies to Action - Pertinax Pharma Limited, UK
6.7 Companies to Action - Chamgonano, China

7. Appendix
7.1 Summary of Key Contacts

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allvivo Vascular Inc., US
  • Chamgonano, China
  • Pertinax Pharma Limited, UK
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll